Therapy resistance remains a central barrier to durable clinical benefit across cancer types, limiting the long-term efficacy of chemotherapy, targeted therapies, and immunotherapy. Although genetic alterations contribute to resistance, increasing evidence ind... ...

请注册登录后继续浏览